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Dear Mr L,
We met on my first day of clinic during fellowship.
Perhaps knowing I was a first year, you sheepishly
introduced yourself by highlighting your expertise as
a self-described old hat at “this whole cancer thing.” By
then, you had already been dutifully coming to the clinic
month after month for your regular multiple myeloma
checkups and treatment rounds. I recall being struck by
how cancer seemed unable to hold you back, as if you
would let anything get in the way of your plans. This
became especially clear when as a senior citizen, you
casually mentioned how you were still lifting large ob-
jects, such as old washing machines, by yourself onto
your truck. Many men 40 years younger would not have
been able to keep up with your daily pace.
I stumbled throughmy first few appointments with you.
It was hard enough to learn how to even pronounce the
names of some of the drugs you were taking, never
mind keeping track of all the adverse effects they could
cause. Still, you never complained about my lack of
experience and let me grow as a clinician. As the
months wore on, I would see your name pop up
without fail on my clinic list while precharting every 4
weeks. You would just saunter in, proudly wearing your
“USA Veteran” hat, with your trusty custom-made
cane always at your side. Over time, as my clinical
skills and confidence improved, so did our banter.
We built up our own routine. You would come into the
clinic and always tell me about your latest scrap metal
find. An old dishwasher, a beat up drier, the occasional
fridge—your excitement never waned as you described
each item and carefully explained how the prices might
fare that month. You never had any complaints, or at
least none that you would share, despite me running
through an extensive checkup list each visit. No matter
the question, you insisted the cancer caused you no
pain and claimed that the pills had no adverse effects.
And as our appointment neared its end, you would
joyfully tell me about the restaurant you would head
right on over to and the exact meal you planned on
having. Never a word about your service though; those
memories were for you and you alone.
But then you started getting sick. The man who never
once complained of any symptoms told me that he was
feeling a very slight shortness of breath. Immediately,
a blaring alarm went off inside my head, and you were
quickly found to have bilateral pneumonia. Over the
next few months, you spent more time in the hospital
than out because of infections, bleeding, and heart
failure exacerbations. Your multiple myeloma started
to rapidly progress, and we had long, hard conver-
sations about quality and quantity of life. And yet, you
nevertheless persevered through all the hospitaliza-
tions and unforeseen complications thrown your way.
With a new treatment plan and a lot of effort, we even
got the myeloma back under control. Everything was
finally starting to go well again.
Then COVID-19 hit, and each day we learned a little
more about this novel infection taking over the world.
You asked what I thought about this new virus, and I
warned that your age and cancer put you in a high-risk
category for morbidity/mortality. And as with every
other patient on active treatment, we carefully weighed
the choices that needed to be made. We discussed
how delaying treatment would risk losing all the
progress we had made in regaining control of your
myeloma. Your agony was palpable as your mind
wrestled between your fear of exposing yourself to
coronavirus and the fresh memory of your recent
hospitalization. These were no easy choices, but I an-
swered your questions as honestly as I could with the
information we had at hand. After much deliberation,
you decided to keep moving forward.
One week later I saw you wander down the hall on my
way to see a different patient. You were here for your
scheduled chemotherapy session, though not in our
regular infusion area. As one of several measures
taken by our hospital, chemotherapy sessions were
being conducted in isolation. I know this change was
hard for you because the companionship of family
members and other veterans always seemed to lift your
spirits. It was harder that week still because I knew you
had just reached a milestone birthday, something you
frequently mentioned looking forward to. And so, I
made it a point to stop by for a quick hello so that you
would know our team was there for you to share both
the good days and the bad. You grinned from ear to ear
when I congratulated you and gushed about the
double-chocolate cake you planned to eat in cele-
bration. As mundane as our conversation may have
seemed, I will never forget our exchange that day, as it
would end up being our last.
It was about 2 weeks later that I got the call. One of my
colleagues, a pulmonary critical care fellow who I had
known since residency wanted to let me know that you
had been admitted earlier in the day. He told me you
were currently in the intensive care unit (ICU) in our
new COVID-19 ward and that your result had come
back positive. You were on oxygen, and given your age
and cancer, our ICU physicians were very worried
about how you would do. My heart sank as I listened to
my colleague describe your condition.
Once I finished my clinic duties for the day, I headed
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things were faring. There was a nurse stationed outside the
entrance checking badges beside a large sign warning that
absolutely no visitors were allowed. As I made my way
inside, I was immediately greeted with rows of intubated
patients, each in a room behind glass doors. All staff
members understood the severity of the crisis we were
faced with. What we did not yet know, though, is that our
COVID-19 ward would quickly double in size to try to keep
up with the influx of new cases.
After some time, I made it to the room you were in. Looking
through the glass, I saw you resting on an ICU bed and was
taken aback by how fragile you seemed. Your dentures
were lying on a small table, your signature hat and cane
were nowhere to be found, and your body seemed to
struggle with each pained breath. A respiratory therapist,
unrecognizable because of personal protective equipment
obscuring everything but their eyes, was uptitrating your
Optiflow. Since I could not come in, I tried to wave from the
door to get your attention. I hoped that you might find some
peace in seeing a familiar face, but it was to no avail. You
were too disoriented, drifting in and out of consciousness.
Could we have prevented this? Should I have stopped you
from continuing the chemotherapy at least until the situ-
ation seemed better contained? Was it coming to the clinic
that caused you to be exposed in the first place, or did you
catch the disease somewhere else? Is there anything else I
could have done to help to keep you safe? Although deep
down I knew we had done all we could, my mind was still
riddled with questions.
You died alone a couple of days later. Because of the risks
involved with the virus spreading, no family members were
allowed in the room. Your condition had quickly worsened
and as your power of attorney, your grandson made the
heart-wrenching decision to withdraw care. But although
you have joined the ranks of more than 180,000 confirmed
others who were felled by this disease, you will never be just
another statistic to me. I will forever be grateful for your
kindness and for giving me the chance to grow into the
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